JCJolanta Czerwińska

Jolanta Czerwińska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jolanta Czerwińska has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Altered lipid profile in mice lacking the DNA repair protein ERCC1

    by Dorota Dziuban-Lech, Agata Lipko, Andria R. Robinson, Jolanta Czerwińska-Kostrzewska, Barbara Tudek, Laura J. Niedernhofer, Ewa Swiezewska, Elżbieta Speina

  • Mitochondrial RNA, a new trigger of the innate immune system

    by Joanna Grochowska, Jolanta Czerwinska, Lukasz S. Borowski, Roman J. Szczesny

    Mitochondria play a pivotal role in numerous cellular processes. One of them is regulation of the innate immune pathway. In this instance, mitochondria function in two different aspects of regulatory mechanisms. First, mitochondria are part of the antiviral signaling cascade that is triggered in the cytoplasm and transmitted to effector proteins through mitochondria‐localized proteins. Second, mitochondria can become an endogenous source of innate immune stimuli. Under some pathophysiological conditions, mitochondria release to the cytoplasm immunogenic factors, such as mitochondrial nucleic acids. Here, we focus on immunogenic mitochondrial double‐stranded RNA (mt‐dsRNA) and its origin and metabolism. We discuss factors that are responsible for regulating mt‐dsRNA and its escape from mitochondria, emphasizing the contribution of polynucleotide phosphorylase (PNPase, PNPT1). Finally, we review current knowledge of the role of PNPase in human health and disease.This article is categorized under: RNA in Disease and Development > RNA in Disease


  • ERCC1-deficient cells and mice are hypersensitive to lipid peroxidation

    by Jolanta Czerwińska, Małgorzata Nowak, Patrycja Wojtczak, Dorota Dziuban-Lech, Jarosław M. Cieśla, Daria Kołata, Beata Gajewska, Anna Barańczyk-Kuźma, Andria R. Robinson, Hillary L. Shane, et al.


  • Open Access

    Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

    by Andria R. Robinson, Matthew J. Yousefzadeh, Tania A. Rozgaja, Jin Wang, Xuesen Li, Jeremy S. Tilstra, Chelsea H. Feldman, Siobhán Q. Gregg, Caroline H. Johnson, Erin M. Skoda, et al.


  • Open Access

    Oxidation Products of 5-Methylcytosine are Decreased in Senescent Cells and Tissues of Progeroid Mice

    by Ewelina Zarakowska, Jolanta Czerwinska, Agnieszka Tupalska, Matt J Yousefzadeh, Siobhán Q Gregg, Claudette M St. Croix, Laura J Niedernhofer, Marek Foksinski, Daniel Gackowski, Anna Szpila, et al.

    5-Hydroxymethylcytosine and 5-formylcytosine are stable DNA base modifications generated from 5-methylcytosine by the ten-eleven translocation protein family that function as epigenetic markers. 5-Hydroxymethyluracil may also be generated from thymine by ten-eleven translocation enzymes. Here, we asked if these epigenetic changes accumulate in senescent cells, since they are thought to be inversely correlated with proliferation. Testing this in ERCC1-XPF-deficient cells and mice also enabled discovery if these DNA base changes are repaired by nucleotide excision repair. Epigenetic marks were measured in proliferating, quiescent and senescent wild-type and Ercc1-/- primary mouse embryonic fibroblasts. The pattern of epigenetic marks depended more on the proliferation status of the cells than their DNA repair capacity. The cytosine modifications were all decreased in senescent cells compared to quiescent or proliferating cells, whereas 5-(hydroxymethyl)-2’-deoxyuridine was increased. In vivo, both 5-(hydroxymethyl)-2’-deoxyuridine and 5-(hydroxymethyl)-2’-deoxycytidine were significantly increased in liver tissues of aged wild-type mice compared to young adult wild-type mice. Livers of Ercc1-deficient mice with premature senescence and aging had reduced level of 5-(hydroxymethyl)-2’-deoxycytidine and 5-formyl-2’-deoxycytidine compared to aged-matched wild-type controls. Taken together, we demonstrate for the first time, that 5-(hydroxymethyl)-2’-deoxycytidine is significantly reduced in senescent cells and tissue, potentially yielding a novel marker of senescence.


  • Open Access

    N-(4-Bromobenzyl)-2-(5,6-dimethyl-1H-benzo[d]imid-azol-2-yl)benzeneamine

    by Monika Dziełak, Damian Trzybiński, Jolanta Czerwińska, Bartosz Majchrzak, Barbara Tudek, Krzysztof Woźniak, Adam Mieczkowski

    N-(4-Bromobenzyl)-2-(5,6-dimethyl-1H-benzo[d]imidazol-2-yl)benzeneamine was obtained by condensation of N-(4-bromobenzyl)-3,1-benzoxazine-2,4-dione (N-(4-bromobenzyl)isatoic anhydride) with 4,5-dimethyl-1,2-phenylenediamine in refluxing acetic acid. This is a rare example of condensation of N-substituted 3,1-benzoxazine-2,4-dione with 1,2-phenylenediamine, which resulted in the formation of a benzimidazole derivative with a moderate yield. Crystallographic studies and initial biological screening were performed for the obtained product.


  • Open Access

    5-Methyl-3,8-di-(2-amino-4-bromophenyl)-4,9-dioxa-1,2,6,7-tetraaza-5λ5-phosphaspiro[4.4]nona-2,7-diene

    by Sławomir Kasperowicz, Jolanta Czerwińska, Bartosz Majchrzak, Barbara Tudek, Adam Mieczkowski

    5-Methyl-3,8-di-(2-amino-4-bromophenyl)-4,9-dioxa-1,2,6,7-tetraaza-5λ5-phosphaspiro[4.4]nona-2,7-diene was obtained by condensation of 2-amino-5-bromobenzohydrazide and methylphosphonyl dichloride in the presence of triethylamine. An initial biological screening was performed for the resulting product. The synthesized compound showed relatively strong cytotoxic activity, which was, however, similar for cancer and non-cancer cell lines.

  • Open Access

    5-Methyl-3,8-di-(2-amino-4-bromophenyl)-4,9-dioxa-1,2,6,7-tetraaza-5λ5-phosphaspiro[4.4]nona-2,7-diene – Synthesis and Preliminary Cytotoxic Screning

    by Sławomir Kasperowicz, Jolanta Czerwińska, Bartosz Majchrzak, Barbara Tudek, Adam Mieczkowski

    5-Methyl-3,8-di-(2-amino-4-bromophenyl)-4,9-dioxa-1,2,6,7-tetraaza-5λ5-phosphaspiro[4.4]nona-2,7-diene was obtained in a condensation reaction of 2-amino-5-bromobenzohydrazide and methylphosphonyl dichloride in the presence of triethylamine. An initial biological screening was performed for the obtained product. The synthesized compound possesses two aromatic primary amine groups and two bromine atoms within the structure, which are suitable for further structural modifications.

  • Open Access

    Catalytic activities of Werner protein are affected by adduction with 4-hydroxy-2-nonenal

    by Jolanta Czerwińska, Jarosław Poznański, Janusz Dębski, Zuzanna Bukowy, Vilhelm A. Bohr, Barbara Tudek, Elżbieta Speina

    4-Hydroxy-2-nonenal (HNE) is a reactive α,β-unsaturated aldehyde generated during oxidative stress and subsequent peroxidation of polyunsaturated fatty acids. Here, Werner protein (WRN) was identified as a novel target for modification by HNE. Werner syndrome arises through mutations in the WRN gene that encodes the RecQ DNA helicase which is critical for maintaining genomic stability. This hereditary disease is associated with chromosomal instability, premature aging and cancer predisposition. WRN appears to participate in the cellular response to oxidative stress and cells devoid of WRN display elevated levels of oxidative DNA damage. We demonstrated that helicase/ATPase and exonuclease activities of HNE-modified WRN protein were inhibited both in vitro and in immunocomplexes purified from the cell extracts. Sites of HNE adduction in human WRN were identified at Lys577, Cys727, His1290, Cys1367, Lys1371 and Lys1389. We applied in silico modeling of the helicase and RQC domains of WRN protein with HNE adducted to Lys577 and Cys727 and provided a potential mechanism of the observed deregulation of the protein catalytic activities. In light of the obtained results, we postulate that HNE adduction to WRN is a post-translational modification, which may affect WRN conformational stability and function, contributing to features and diseases associated with premature senescence.